Q: What need is Exact Sciences Corporation addressing? A: Exact Sciences’ mission is to improve patient outcomes through the early detection of cancer. We are especially focused on developing highly accurate, minimally invasive screening tests and technologies....
Q: What need is Biocept, Inc addressing? A: Physicians are not receiving all the genomic information needed for precision medicine therapeutic decision making so some patients potentially miss out on targeted therapies that could save or extend their lives....
Q: How do you select startup companies you invest in? What are values you are looking for both in the companies and the leadership teams? A: This answer is more of a philosophical one rather than a simple listing of ingredients, even though the latter might...
The microbiome significantly impacts human health, playing a crucial role in maintaining health and preventing disease. It influences endocrinology, physiology, and even neurology, altering the outcome of many different disease states, and it has been shown to augment drug responses and tolerance. In parallel to...
Q: What is your vision for personalized care? A: While the term “personalized care” has become popular contemporary with the maturation of genomic medicine, it is clear that the entire context of care – including social, behavioral, and environmental factors – drives the outcomes we are...
Q1a: You are the Deputy Director of the All of Us Research Program. What is your role as the deputy director and why is this initiative so important? A: As deputy director, my primary role is to work closely with the All of Us Director Eric...
Q: Why is the microbiome so important in the context of precision medicine? A: We can’t ignore a part of our body that is composed of tens and tens of trillions cells, albeit microbial - a population that collectively contains at least two orders of...
Q: What need is IBM and Health2047 addressing in the healthcare/life sciences sector? Jason (IBM): The industry is undergoing a significant transformation as reimbursement shifts from fee-for-service to value-based outcomes in the face of regulatory uncertainty....
Q: What are the objectives of the Human Proteome Project and what are some of the recent breakthrough discoveries? The HUPO Human Proteome Project has two overarching goals: (1) to complete the protein parts list, with at least one protein product from each of the ~20,000 protein-coding...
Q: What are some of the biggest contributors to these challenges and how can we overcome them? A: One of the underlying challenges driving the rising the cost of health care is that most of the health system’s stakeholders have few incentives, if not outright disincentives,...
